Hans‐Wolfgang Klafki

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Jens Wiltfang, Hermann Esselmann, Mirko Bibl et al. · Journal of Neurochemistry · 2002 · 272 citations · Full text

Life Sciences, Neurology, Neuroscience +14

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice

Sylvie Le Corre, Hans‐Wolfgang Klafki, Nikolaus Plesnila et al. · Proceedings of the National Academy of Sciences · 2006 · 221 citations · Full text

Life Sciences, Neurology, Neuroscience +17

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Mirko Bibl, Brit Mollenhauer, Hermann Esselmann et al. · Brain · 2006 · 208 citations · Full text

Medicine, Neurology, Neuroscience +17

Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

Melanie Hüttenrauch, Isabella Ogorek, Hans‐Wolfgang Klafki et al. · Acta Neuropathologica Communications · 2018 · 173 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Volker Welge, Oliver Fiege, Piotr Lewczuk et al. · Journal of Neural Transmission · 2009 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +15